[Cancer Research 64, 9057-9061, December 15, 2004]
© 2004 American Association for Cancer Research
c-Jun NH2-Terminal Kinase Activation Contributes to Hypoxia-Inducible Factor 1
–Dependent P-Glycoprotein Expression in Hypoxia
Katrina M. Comerford,
Eoin P. Cummins and
Cormac T. Taylor
Department of Medicine and Therapeutics, The Conway Institute for Biomolecular and Biomedical Research and the Dublin Molecular Medicine Centre, University College, Dublin, Ireland
We previously have shown that hypoxia increases the expression of P-glycoprotein, which in turn increases tumor cell capacity to actively extrude chemotherapeutic agents and may contribute to tumor drug resistance. This event is mediated through the hypoxia-inducible factor (HIF-1). Here, we investigated the role of the stress-activated protein kinase c-Jun NH2-terminal kinase (JNK) in the signaling mechanisms underlying these events. Hypoxia activates JNK activity in vitro and in vivo. Overexpression of mitogen-activated protein kinase (MAPK) kinase kinase (MEKK-1), which preferentially activates JNK, mimics, in a nonadditive way, hypoxia-induced activity of the MDR1 promoter and expression of MDR1 mRNA and P-glycoprotein. Furthermore, the JNK inhibitor SP600125 selectively and specifically inhibits hypoxia- and MEKK-1–induced MDR1 promoter activity in a dose-dependent manner. JNK inhibition also reversed hypoxia- and MEKK-1–induced activity of an HIF-1–dependent reporter gene. MEKK-1–induced MDR1 expression depends on a functional HIF-1 binding site (hypoxia-responsive element). Hypoxia- but not cobalt chloride–dependent HIF-1–DNA binding and transcriptional activation was inhibited by SP600125, indicating that hypoxia-induced signaling to HIF-1 depends on JNK activation. Because it has been reported that reactive oxygen species are increased in hypoxia and related to JNK activation, we investigated their role in signaling this response. Whereas exogenous addition of H2O2 was sufficient to activate JNK, reactive oxygen species scavengers were without effect on hypoxia-induced JNK or HIF-1 activation. Thus, hypoxia-elicited MDR1 expression, which depends on HIF-1 activation, depends at least in part on signaling via activation of JNK. Furthermore, these events are independent of the generation of reactive oxygen intermediates. Thus, JNK may represent a therapeutic target in the prevention of tumor resistance to chemotherapeutic treatment.
This article has been cited by other articles:
|
|
|
|
 
C. K. Lau, Z. F. Yang, D. W. Ho, M. N. Ng, G. C.T. Yeoh, R. T.P. Poon, and S. T. Fan
An Akt/Hypoxia-Inducible Factor-1{alpha}/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
Clin. Cancer Res.,
May 15, 2009;
15(10):
3462 - 3471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, J. Gao, W. Dai, and L. Lu
Activation of Polo-like Kinase 3 by Hypoxic Stresses
J. Biol. Chem.,
September 19, 2008;
283(38):
25928 - 25935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-N. Jung, W. K. Yang, J. Kim, H. S. Kim, E. J. Kim, H. Yun, H. Park, S. S. Kim, W. Choe, I. Kang, et al.
Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells
Carcinogenesis,
April 1, 2008;
29(4):
713 - 721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr
P-glycoprotein: So Many Ways to Turn It On
J. Clin. Pharmacol.,
March 1, 2008;
48(3):
365 - 378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Blanco, C. Santos, and P. A. Lazo
Vaccinia-Related Kinase 2 Modulates the Stress Response to Hypoxia Mediated by TAK1
Mol. Cell. Biol.,
October 15, 2007;
27(20):
7273 - 7283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Liu, D. Li, R. Aneja, H. C. Joshi, S. Xie, C. Zhang, and J. Zhou
PO2-dependent Differential Regulation of Multidrug Resistance 1 Gene Expression by the c-Jun NH2-terminal Kinase Pathway
J. Biol. Chem.,
June 15, 2007;
282(24):
17581 - 17586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. R. Rezvani, S. Dedieu, S. North, F. Belloc, R. Rossignol, T. Letellier, H. de Verneuil, A. Taieb, and F. Mazurier
Hypoxia-inducible Factor-1{alpha}, a Key Factor in the Keratinocyte Response to UVB Exposure
J. Biol. Chem.,
June 1, 2007;
282(22):
16413 - 16422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Fradette, J. Batonga, S. Teng, M. Piquette-Miller, and P. du Souich
Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver
Drug Metab. Dispos.,
May 1, 2007;
35(5):
765 - 771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Prasad, A. Chandra, C. K. Mukhopadhyay, and R. Prasad
Unexpected Link between Iron and Drug Resistance of Candida spp.: Iron Depletion Enhances Membrane Fluidity and Drug Diffusion, Leading to Drug-Susceptible Cells
Antimicrob. Agents Chemother.,
November 1, 2006;
50(11):
3597 - 3606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev,
October 1, 2006;
86(4):
1179 - 1236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Mense, A. Sengupta, M. Zhou, C. Lan, G. Bentsman, D. J. Volsky, and L. Zhang
Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes
Physiol Genomics,
May 16, 2006;
25(3):
435 - 449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhou, M. Liu, R. Aneja, R. Chandra, H. Lage, and H. C. Joshi
Reversal of P-glycoprotein-Mediated Multidrug Resistance in Cancer Cells by the c-Jun NH2-Terminal Kinase
Cancer Res.,
January 1, 2006;
66(1):
445 - 452.
[Abstract]
[Full Text]
[PDF]
|
|
|
Copyright © 2004 by the American Association for Cancer Research.
